Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person:  The calculation is based upon 24,979,153 shares of Common Stock beneficially owned as of 09/30/2026 and a total of 394,790,441 shares of Common Stock, $0.001 par value per share, outstanding as of November 1, 2026, as reported by the Issuer on its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:  The calculation is based upon 24,979,153 shares of Common Stock beneficially owned as of 09/30/2026 and a total of 394,790,441 shares of Common Stock, $0.001 par value per share, outstanding as of November 1, 2026, as reported by the Issuer on its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:  The calculation is based upon 24,979,153 shares of Common Stock beneficially owned as of 09/30/2026 and a total of 394,790,441 shares of Common Stock, $0.001 par value per share, outstanding as of November 1, 2026, as reported by the Issuer on its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2026.


SCHEDULE 13G



 
MAK Capital Fund LP
 
Signature:/s/ Michael A. Kaufman
Name/Title:Managing Member
Date:11/16/2026
 
MAK CAPITAL ONE LLC
 
Signature:/s/ Michael A. Kaufman
Name/Title:Managing Member
Date:11/16/2026
 
Kaufman Michael A
 
Signature:/s/ Michael A. Kaufman
Name/Title:Michael A. Kaufman
Date:11/16/2026
Exhibit 99.1

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as
amended, the persons named below agree to the joint filing on behalf of each
of them of a statement on Schedule 13G/A (including amendments thereto) with
respect to the Common Stock, $0.001 par value per share, of Standard BioTools
Inc. and further agree that this Joint Filing Agreement be included as an
Exhibit to such joint filings. It is understood and agreed that the joint
filing of the Schedule 13G/A shall not be construed as an admission that the
persons named herein constitute a group for purposes of Regulation 13D-G of
the Securities Exchange Act of 1934, as amended.

Dated: November 16, 2026


MAK CAPITAL FUND LP

By: MAK GP LLC, general partner
By: /s/ Michael A. Kaufman
    -----------------------------
    Michael A. Kaufman, Managing Member


MAK CAPITAL ONE L.L.C.

By: /s/ Michael A. Kaufman
    -----------------------------
    Michael A. Kaufman, Managing Member


/s/ Michael A. Kaufman
-----------------------------
MICHAEL A. KAUFMAN